Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOther Non-Current AssetsPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

ReposiTrak (TRAK) Common Equity (2016 - 2025)

ReposiTrak has reported Common Equity over the past 15 years, most recently at $49.7 million for Q4 2025.

  • Quarterly results put Common Equity at $49.7 million for Q4 2025, up 3.73% from a year ago — trailing twelve months through Dec 2025 was $49.7 million (up 3.73% YoY), and the annual figure for FY2025 was $49.5 million, up 5.69%.
  • Common Equity for Q4 2025 was $49.7 million at ReposiTrak, down from $50.2 million in the prior quarter.
  • Over the last five years, Common Equity for TRAK hit a ceiling of $50.2 million in Q3 2025 and a floor of $42.8 million in Q1 2022.
  • Median Common Equity over the past 5 years was $45.8 million (2023), compared with a mean of $46.2 million.
  • Biggest five-year swings in Common Equity: rose 7.16% in 2021 and later dropped 5.08% in 2022.
  • ReposiTrak's Common Equity stood at $45.5 million in 2021, then decreased by 2.7% to $44.3 million in 2022, then rose by 3.36% to $45.7 million in 2023, then increased by 4.79% to $47.9 million in 2024, then rose by 3.73% to $49.7 million in 2025.
  • The last three reported values for Common Equity were $49.7 million (Q4 2025), $50.2 million (Q3 2025), and $49.5 million (Q2 2025) per Business Quant data.